CUSIP 483497103COMKALVQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
161 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Vr Adviser, LLC | 6.73M | $108.67M | 0 | Held |
| 2 | Frazier Life Sciences Management, L.P. | 5.04M | $81.39M | 0 | Held |
| 3 | Suvretta Capital Management, LLC | 4.77M | $77.01M | 0 | Held |
| 4 | Tang Capital Management LLC | 4.57M |
| $73.86M |
| −468.3K |
| Reduced |
| 5 | Blackrock, Inc. | 3.75M | $60.63M | +628.0K | Added |
| 6 | Millennium Management LLC | 2.90M | $46.78M | +800.4K | Added |
| 7 | Capital World Investors | 2.81M | $45.36M | −369.0K | Reduced |
| 8 | Vanguard Group Inc | 2.51M | $40.52M | +7.9K | Added |
| 9 | Silverarc Capital Management, LLC | 2.43M | $39.20M | +1.06M | Added |
| 10 | Point72 Asset Management, L.P. | 2.28M | $36.88M | +2.28M | New |
See every fund holding Kalvista Pharmaceuticals Inc, with full quarter-over-quarter share changes.
Unlock all holders